Auxly Cannabis Group Inc. (TSX: XLY) Stock Analysis & Fundamentals

XLYAuxly Cannabis Group Inc.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · auxly.com

3.130CAD+0.97%Mkt Cap: 228.76M $P/E: 10.00Today

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap228.76M $

Enterprise Value246.98M $

Revenue (TTM)120.58M $

Gross Profit63.17M $

Net Income (TTM)30.48M $

Revenue/Share1.227 USD

Last Price3.130 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees446

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA05335P1099

Valuation

P/E (Trailing)10.00

P/E (Forward)13.62

PEG—

EV/EBITDA8.54

EV/Revenue2.05

P/S1.96

P/B23.97

EPS (TTM)0.31

EPS (Forward)0.23

52W Range

1.54090% of range3.300

52W High3.300 CAD

52W Low1.540 CAD

Profitability

Gross Margin57.26%

Oper. Margin18.97%

EBITDA Margin23.99%

Profit Margin27.63%

ROE23.57%

ROA15.41%

Growth

Revenue Growth18.00%

Earnings Growth-12.50%

Cash Flow & Leverage

Operating CF19.08M $

CapEx (TTM)1.83M $

FCF Margin1.56%

FCF Yield0.82%

Net Debt10.90M $

Net Debt/EBITDA0.38

Balance Sheet

Debt/Equity0.32

Current Ratio2.35

Quick Ratio1.43

Book Value/Sh0.1310 CAD

Cash/Share0.3750 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:14

Split DateJul 28, 2026

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.000 CAD

Upside (mean)+27.8%

Target Range4.000 CAD – 4.000 CAD

# Analysts1

Ownership

Shares Out.103.24M

Float78.15M

Insiders23.05%

Institutions0.63%

Short Interest

Short Ratio0.8d

Short % Out.0.05%

Shares Short577.00K

Short (prev mo.)554.80K

Technical

SMA 502.626 (+19.2%)

SMA 2002.128 (+47.1%)

Beta1.19

S&P 52W Chg18.16%

Avg Vol (30d)96.78K

Avg Vol (10d)175.84K

Technical Indicators

RSI (14)66.1

MACD0.1728

MACD Signal0.1399

MACD Hist.+0.0329

BB Upper3.295 CAD

BB Middle2.774 CAD

BB Lower2.253 CAD

BB Width37.56%

ATR (14)0.1905 CAD

Vol Ratio (20d)0.92x